Determinants of glycaemic outcome in the current practice of care for young people up to 21 years old with type 1 diabetes under real-life conditions.
Adolescent
Blood Glucose Self-Monitoring
Child
Child, Preschool
Diabetes Mellitus, Type 1
/ drug therapy
Female
Glycated Hemoglobin
/ metabolism
Humans
Hypoglycemic Agents
/ therapeutic use
Infant
Infusion Pumps, Implantable
Insulin
/ therapeutic use
Insulin Infusion Systems
Male
Monitoring, Ambulatory
Patient Care Team
Prevalence
Self Care
Treatment Outcome
Young Adult
Journal
Diabetic medicine : a journal of the British Diabetic Association
ISSN: 1464-5491
Titre abrégé: Diabet Med
Pays: England
ID NLM: 8500858
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
accepted:
05
09
2019
pubmed:
10
9
2019
medline:
8
9
2021
entrez:
10
9
2019
Statut:
ppublish
Résumé
To determine factors influencing the success of treatment for type 1 diabetes, defined as HbA This is a monocentric observational study analysing the determinants of glycaemic outcome (sex, age, comorbidities, sociodemographic factors, diabetes technology) in an entire cohort of people with diabetes aged up to 21 years. Glycaemic outcome was defined as an individual's median HbA Of 700 young people with type 1 diabetes [age 13.6 years (range: 1.4-20.9 years); diabetes duration 5.8 years (range: 0.1-18.3 years)], 63% were using an insulin pump and 32% any type of continuous glucose monitoring. Mean HbA Current technologies and a multidisciplinary team approach allow high numbers of children and adolescents to realize tight glycaemic control with a low prevalence of acute complications. However, age-related challenges, sociodemographic factors and psychological comorbidities are barriers to achieving best possible glycaemic outcome.
Substances chimiques
Glycated Hemoglobin A
0
Hypoglycemic Agents
0
Insulin
0
hemoglobin A1c protein, human
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
797-804Informations de copyright
© 2019 Diabetes UK.
Références
Rawshani A, Sattar N, Franzén S, Rawshani A, Hattersley A, Svensson AM et al. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet 2018; 392: 477-486.
Sauder KA, Stafford JM, Mayer-Davis EJ, Jensen ET, Saydah S, Mottl A et al.; SEARCH for Diabetes in Youth Study Group. Co-occurrence of early diabetes-related complications in adolescents and young adults with type 1 diabetes: an observational cohort study. Lancet Child Adolesc Health 2019; 3: 35-43.
Schwandt A, Bergis D, Denkinger M, Gollisch KSC, Sandig D, Stingl H et al. Risk factors for decline in renal function among young adults with type 1 diabetes. J Diabetes Complicat 2018; 32: 940-946.
Aye T, Mazaika PK, Mauras N, Marzelli MJ, Shen H, Hershey T et al.; Diabetes Research in Children Network (DirecNet) Study Group. Impact of early diabetic ketoacidosis on the developing brain. Diabetes Care 2019; 42: 443-449.
Charalampopoulos D, Hermann JM, Svensson J, Skrivarhaug T, Maahs DM, Akesson K et al. Exploring variation in glycemic control across and within eight high-income countries: a cross-sectional analysis of 64,666 children and adolescents with type 1 diabetes. Diabetes Care 2018; 41: 1180-1187.
de Beaufort CE, Lange K, Swift PG, Aman J, Cameron F, Castano L et al.; The Hvidoere Study Group. Metabolic outcomes in young children with type 1 diabetes differ between treatment centers: the Hvidoere Study in Young Children 2009. Pediatr Diabetes 2013; 14: 422-428.
Skinner TC, Lange K, Hoey H, Mortensen H, Swift P, Aanstoot HJ et al.; The Hvidoere Study Group. Targets and teamwork: understanding differences in paediatric diabetes centres treatment outcomes. Pediatr Diabetes 2018; 19: 559-565.
Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH et al. International consensus on use of continuous glucose monitoring. Diabetes Care 2017; 40: 1631-1640.
Burckhardt MA, Smith GJ, Cooper MN, Jones TW, Davis EA. Real-world outcomes of insulin pump compared to injection therapy in a population-based sample of children with type 1 diabetes. Pediatr Diabetes 2018; 19: 1459-1466.
Kordonouri O, Hartmann R, Pankowska E, Rami B, Kapellen T, Coutant R et al. Sensor augmented pump therapy from onset of type 1 diabetes: late follow-up results of the Pediatric Onset Study. Pediatr Diabetes 2012; 13: 515-518.
Patterson CC, Harjutsalo V, Rosenbauer J, Neu A, Cinek O, Skrivarhaug T et al. Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989-2013: a multicentre prospective registration study. Diabetologia 2019; 62: 408-417.
Harrington KR, Boyle CT, Miller KM, Hilliard ME, Anderson BJ, van Name M et al.; T1D Exchange Clinic Network. Management and family burdens endorsed by parents of youth < 7 years old with type 1 diabetes. J Diabetes Sci Technol 2017; 11: 980-987.
American Diabetes Association: Children and adolescents: standards of medical care in Diabetes. Diabetes Care 2018; 41(Suppl 1): 126-136.
Pihoker C, Forsander G, Fantahun B, Virmani A, Corathers S, Benitez-Aguirre P et al. ISPAD Clinical Practice Consensus Guidelines 2018: The delivery of ambulatory diabetes care to children and adolescents with diabetes. Pediatr Diabetes 2018; 19(Suppl 27): 84-104.
Phelan H, Lange K, Cengiz E, Gallego P, Majaliwa E, Pelicand J et al. ISPAD Clinical Practice Consensus Guidelines 2018: diabetes education in children and adolescents. Pediatr Diabetes 2018; 19(Suppl 27): 75-83.
Lange K, Kordonouri O. Setting the right course at type 1 diabetes diagnosis. Lancet Child Adolesc Health 2019; 3: 138-139.
Lange K, Klotmann S, Saßmann H, Aschemeier B, Wintergerst E, Gerhardsson P et al.; SWEET group. A paediatric diabetes toolbox for creating centres of reference. Pediatr Diabetes 2012; 13(Suppl 16): 49-61.
Martin D, Lange K, Sima A, Kownatka D, Skovlund S, Danne T et al.; SWEET group. Recommendations for age-appropriate education of children and adolescents with diabetes and their parents in the European Union. Pediatr Diabetes 2012; 13(Suppl 16): 20-28.
DiMeglio LA, Acerini CL, Codner E, Craig ME, Hofer SE, Pillay K et al. ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr Diabetes 2018; 19(Suppl 27): 105-114.
Hofer SE, Schwandt A, Holl RW; Austrian/German DPV Initiative. Standardized documentation in pediatric diabetology: experience from Austria and Germany. J Diabetes Sci Technol 2016; 10: 1042-1049.
Danne T, Lion S, Madaczy L, Veeze H, Raposo F, Rurik I et al.; SWEET group. Criteria for Centers of Reference for pediatric diabetes - a European perspective. Pediatr Diabetes 2012; 13(Suppl 16): 62-75.
Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 2007; 4: e296.
Weishaar H, Hurrelmann K, Okan O, Horn A, Schaeffer D. Framing health literacy: a comparative analysis of national action plans. Health Policy 2019; 123: 11-20.
Gehr B, Holder M, Kulzer B, Liebl A1, Sahm C5, von Sengbusch S et al.; SPECTRUM Group. SPECTRUM: a training and treatment program for continuous glucose monitoring for all age groups. J Diabetes Sci Technol 2017; 11: 284-289.
McKnight JA, Wild SH, Lamb MJ, Cooper MN, Jones TW, Davis EA et al. Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabet Med 2015; 32: 1036-1050.
Maahs DM, Hermann JM, DuBose SN, Miller KM, Heidtmann B, DiMeglio LA et al. Contrasting the clinical care and outcomes of 2,622 children with type 1 diabetes less than 6 years of age in the United States T1D Exchange and German/Austrian DPV registries. Diabetologia 2014; 57: 1578-1585.
DeSalvo DJ, Miller KM, Hermann JM, Maahs DM, Hofer SE, Clements MA et al.; T1D Exchange and DPV Registries. Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative. Pediatr Diabetes 2018; 19: 1271-1275.
Hanberger L, Samuelsson U, Holl RW, Fröhlich-Reiterer E, Åkesson K, Hofer S. Type 1 diabetes during adolescence: International comparison between Germany, Austria, and Sweden. Pediatr Diabetes 2018; 19: 506-511.
Sumnik Z, Szypowska A, Iotova V, Bratina N, Cherubini V, Forsander G et al.; SWEET Study Group. Persistent heterogeneity in diabetes technology reimbursement for children with Type 1 Diabetes: The SWEET perspective. Pediatr Diabetes 2019; 20: 434-443.